Loading…
Description of the processes in the value chain and risk assessment of decomposition substances and oxidation products in fish Oils. Opinion of Steering Committee of the Norwegian Scientific Committee for Food Safety
The Norwegian Scientific Committee for Food Safety (VKM) has been asked by the Norwegian Food Safety Authority to perform a health risk assessment on decomposition substances and oxidation products in fish oils intended for human consumption except pharmaceuticals. Seal and/or krill oil intended for...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Report |
Language: | English |
Subjects: | |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The Norwegian Scientific Committee for Food Safety (VKM) has been asked by the Norwegian Food Safety Authority to perform a health risk assessment on decomposition substances and oxidation products in fish oils intended for human consumption except pharmaceuticals. Seal and/or krill oil intended for human consumption might be included but in separate chapters. EU’s hygiene regulations for the production of fish oils intended for human consumption were strengthened from 2008 in the EU (from March 2010 in Norway), but concerns regarding the possible presence of decomposition substances and oxidation products in the oils and their possible consequences on human health were raised.
In the request from the National Food Safety Authority, VKM was asked to include descriptions of the substances resulting from decomposition of the various raw material used for fish oil production, and the products formed during oxidation of marine oils. Additionally, a description of the substances formed and/or eliminated during the various processing steps in the production of marine oils intended for human consumption and to take raw material, processing conditions, storing and transporting conditions of raw material and fish oil into account. Depending on the detectability of the identified substances/products of concern in n-3 fatty acid food supplements, a qualitative, and if possible quantitative, health risk assessment should be performed. |
---|